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Despite perceived challenges to controlling an infectious disease in wildlife,
oral rabies vaccination (ORV) of foxes has proved a remarkably successful
tool and a prime example of a sophisticated strategy to eliminate disease
from wildlife reservoirs. During the past three decades, the implementa-
tion of ORV programmes in 24 countries has led to the elimination of
fox-mediated rabies from vast areas of Western and Central Europe. In
this study, we evaluated the efficiency of 22 European ORV programmes
between 1978 and 2010. During this period an area of almost 1.9 million km2
was targeted at least once with vaccine baits, with control taking between 5
and 26 years depending upon the country. We examined factors influencing
effort required both to control and eliminate fox rabies as well as cost-related
issues of these programmes. The proportion of land area ever affected by
rabies and an index capturing the size and overlap of successive ORV cam-
paigns were identified as factors having statistically significant effects on the
number of campaigns required to both control and eliminate rabies. Repeat
comprehensive campaigns that are wholly overlapping much more rapidly
eliminate infection and are less costly in the long term. Disproportionally
greater effort is required in the final phase of an ORV programme, with a
median of 11 additional campaigns required to eliminate disease once inci-
dence has been reduced by 90 per cent. If successive ORV campaigns span
the entire affected area, rabies will be eliminated more rapidly than if cam-
paigns are implemented in a less comprehensive manner, therefore reducing
ORV expenditure in the longer term. These findings should help improve the
planning and implementation of ORV programmes, and facilitate future
decision-making by veterinary authorities and policy-makers.1. Introduction
Vaccination programmes are one of the most effective means of controlling
infectious diseases [1]. Smallpox and rinderpest have been eradicated through
vaccination programmes in people and cattle, respectively [2,3], and other dis-
eases have been eliminated from large parts of the globe as a result of concerted
vaccination efforts. Yet, wildlife diseases that pose a threat to public health, live-
stock production or conservation are less likely to be considered as candidates
for vaccination programmes owing to the difficulty and expense in the mass
delivery of vaccines to wild animal populations. Indeed, the lack of a wildlife
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2reservoir is considered a prerequisite for a disease to be con-
sidered eradicable [4]. However, with the development of
oral vaccines and bait delivery systems, the elimination of dis-
eases circulating in wildlife populations has become a
tantalizing possibility. The pre-eminent example of vaccination
of wildlife populations is the large-scale oral vaccination pro-
grammes that have eliminated fox rabies from Western
Europe and greatly reduced incidence in Central Europe [5].
Here, we focus on the effectiveness of these programmes,
and the factors underlying the critical transition from disease
control to the ultimate goal of disease elimination.
Rabies is one of the oldest recognized zoonoses, and
is, with the exception of the Antarctic, present worldwide.
The causative agents are negative-strand RNA virus species
(previously genotypes) of the Lyssavirus genus, family
Rhabdoviridae of the Mononegavirales order [6]. Of all Lyssa-
virus species known to date, the prototypic rabies virus
(RABV) is the most important being maintained by a diversity
of abundant canid and viverrid hosts across the world, and
Chiroptera in the Americas [7]. This invariably fatal disease
is a major public health threat [8]. Although human cases are
preventable by prompt administration of post-exposure pro-
phylaxes, control and elimination is only feasible in reservoir
populations, e.g. domestic dogs and foxes, amongst others [9].
Dogs were recognized as a source of rabies infection in
Europe several centuries ago. Over the first half of the twen-
tieth century, measures such as dog movement restriction
and muzzling drastically reduced incidence and led to free-
dom from dog-mediated rabies in some parts of Europe
[10]. With the development and application of mass parent-
eral vaccination, canine rabies was eliminated from the
continent, persisting only in the European part of Turkey
[11]. However, parallel to this success, rabies virus emerged
in red foxes (Vulpes vulpes) south of the Kaliningrad region
following a presumed spillover from domestic dogs. Within
a few decades, the virus was circulating among foxes across
much of Central and Western Europe [12].
Early counteractive control measures aimed exclusively at
reducing fox numbers. These met with only limited success,
and eventually were regarded as counterproductive as they
disrupted the social system of foxes, thereby increasing contact
rates and disease incidence [13]. Mass parenteral vaccination
was not considered to be a viable alternative [12,13]. However,
experiments in the 1970s showed that red foxes could be immu-
nized against rabies by the oral route leading to the concept of
oral rabies vaccination (ORV) [14]. In 1978, the first ORV field
trial was conducted in Switzerland [15] and was followed by
efforts in other European countries, e.g. Germany, France
and Belgium [16]. Thanks to pioneering attempts in a few
countries in Western Europe and financial support from the
European Union (EU) [10], it soon became evident that ORV
was a breakthrough for fox rabies control. National elimina-
tion programmes using ORV were successfully implemented,
and for approved programmes, 50 per cent (since 2010, 75%)
of the costs for vaccine baits and bait distribution were
reimbursed by the EU [10,17]. The EU also promoted the
implementation of ORV programmes in neighbouring non-
EU countries by co-financing a 100 km deep vaccination belt
along common borders. Currently, the EU supports ORV in
the Russian region of Kaliningrad, the Western Balkans and
in northeastern neighbouring countries [18].
ORV programmes have been evaluated for several
countries in Europe, including Belgium [19], Switzerland[20], France [21], the Czech Republic [22], Estonia [23,24],
Germany [25,26] and Italy [27,28]. Prior to the successful
elimination of rabies from countries in Western Europe,
Sto¨hr & Meslin [29] compared the progress and setbacks of
ORV. However, a comparative epidemiological analysis of
ORV across Europe and its success in eliminating rabies has
not been conducted. We, therefore, evaluate the efficiency
of European ORV programmes in terms of controlling and
eliminating fox rabies and we examine cost-related issues of
these programmes. Our findings provide valuable insights
into the effort and tactics required for rabies elimination,
and guidance for decision making in future wildlife vaccina-
tion programmes by veterinary authorities, natural resource
managers and policy-makers.2. Material and methods
(a) Study regions and oral rabies vaccination approach
The study regions encompassed countries from Western, Central
and Eastern Europe that implemented ORV programmes
between 1978 and 2010. Only countries in which more than
four ORV campaigns were conducted during this period were
considered for analysis (detailed in table 1). A standard ORV
approach was applied that typically involved (i) implementation
of ORV campaigns twice a year (spring and autumn), (ii) an aver-
age bait density of 20–25 baits km22, (iii) aerial and manual
distribution of vaccine baits, and (iv) a flight line distance of
500–2000 m in the case of aerial distribution. Occasionally, ORV
campaigns slightly diverged from this protocol. In a few cases,
ORV campaigns were only conducted once a year because of the
specific epidemiological situation (Italy, 1984) or additional cam-
paigns were conducted either in summer or in winter (France,
Germany 2005, Italy 2009) or at short intervals (Germany, 2005;
table 1). During the observation period a total of seven different
SAD (Street Alabama Dufferin) derived oral rabies virus vaccines
were used, including SADBerne [15,23], SADB19 [26,28,30], SAG2
[23,31,32], SAD P5/88, SAG1, SAD VA1 [26], Vnukovo32, and
one recombinant vaccine, i.e. V-RG [33,34]. It is assumed that the
efficacy of the vaccines used is comparable as requirements of
the European Pharmacopoeia had to be met for these vaccines to
be licensed.
(b) Data collection
As part of the terms of reference as a WHO Collaborating Centre
for Rabies Surveillance and Research, national rabies surveillance
data were collected and evaluated. Rabies cases presented here
were laboratory confirmed using standard diagnostic techniques
[35]. Records originated from regular official submissions from
veterinary authorities of European countries to the WHO
Rabies Bulletin Europe database established at the Friedrich–
Loeffler-Institut (FLI), where rabies cases in different species
are summarized for regions on a quarterly basis [36]. Surveil-
lance was generally passive, based on submission of specimens
by veterinarians, hunters, wildlife managers and the general
public. International recommendations for rabies surveillance
vary but suggest that either at least four or eight foxes per 100
km2 be tested annually [8,37,38]. Additionally, specimens
obtained for monitoring of ORV campaigns were also examined.
However, this surveillance, consisting of random sampling of
foxes from the regular hunting bag (not suspect for rabies),
revealed only a very small number of additional cases to those
obtained through passive means.
For each country, annual animal rabies cases (not including bat
rabies) from the year of the first implementation of ORV cam-
paigns until the year of the last wildlife-mediated rabies case
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4(rabies-free countries) or the year 2010 (rabies-endemic countries)
were used for analysis. Additionally, for each country, data related
to theORV programmeswere requested, including the size of indi-
vidual vaccination areas, the timing of vaccination campaigns, bait
density, mode of bait distribution and oral rabies virus vaccine
strains used. For each vaccination campaign, e.g. in spring, in
summer, in autumn or in winter, the size and location of vacci-
nation areas was either requested as shape files or, if not
available, as scanned maps. In the latter case, vaccination areas
were digitized and converted into a GIS database (ArcGIS, Esri
Inc., Redlands, CA, USA), as previously described [39].
(c) Data analysis
We used a Cox-proportional hazard model [40] to investigate fac-
tors influencing the effort (number of campaigns) required to
control and ultimately eliminate fox rabies through ORV. We
used the number of ORV campaigns required for control, perma-
nent control and elimination as the baseline hazard function,
which was right censored for ORV programmes that had not
achieved these endpoints by 2010. In this study, elimination
was defined as a reduction of cases to zero. The fact that this situ-
ation has to be maintained for a minimum of 2 years after the last
detected rabies case for a country to be officially recognized as
rabies-free was not considered here. We defined control as a rela-
tive reduction in annual rabies cases by more than 90 per cent
compared with initial endemic levels prior to implementation
of ORV. We differentiated between control, when incidence is
reduced by at least 90 per cent, but may subsequently increase,
and permanent control, whereupon the 90 per cent reduction
in rabies cases is maintained.
We considered the following variables as potential factors
influencing the baseline hazard of effort required to control
and eliminate fox rabies from a country: the size of the country
(in km2); the area and proportion of the territory that was
ever vaccinated (area given in km2); the length of borders to neigh-
bouring rabies-infected (endemic) areas (in km); initial rabies
incidence in the year prior to the implementation of ORV,
expressed both as the number of detected cases and the number
of detected cases per square kilometre; years of ORV experience
prior to each country starting an ORV programme; and an index
that captures the contiguity and overlap of consecutive ORV cam-
paigns carried out in a country ([41]; table 2). Areas were log
transformed, and proportions logit transformed, prior to statistical
analysis. The best fitting model was selected using a stepwise
algorithm that minimizes the Akaike information criterion.
For any fox rabies endemic area covered at least once with vac-
cine baits during the course of an ORV programme, we assumed
that the rabies-affected area corresponded to the maximum area
ever vaccinated in that country (Vmax in km
2). Vaccination areas
were mostly bounded by administrative borderlines or natural bar-
riers. The mean area index, I, is a metric designed to capture the
comprehensiveness of ORV programmes in terms of the extent of
spatial overlap of consecutive ORV campaigns (d) and the pro-
portion of the endemic area covered, for the duration of the
programme. The index is calculated from the area and overlap of
consecutive campaigns t (t. 1) according to the following
equations:
I ¼ 1
T
XT
t¼2
It ð2:1Þ
It ¼ dtVt1
Vt
Vmax
ð2:2Þ
with Vt, the size of the vaccinated area at campaign t, and dt is the
intersection of successive campaigns Vt and Vt21. The index varies
from zero to one, from campaigns that are entirely non-overlapping
to those that entirely overlap and are equal in size to the maximum
area ever vaccinated [41]. If ORV campaigns were interrupted for
Table 2. Variables in the statistical analysis of factors affecting the control and elimination of fox rabies using ORV.
variable deﬁnition
initial cases, N, and initial cases per
square km, Nkm2
the annual number of cases detected in the year when ORV began in a country, also expressed in terms of
the number of cases detected per square kilometre (N/vAmax)
vaccinated area, Vmax the maximum area (km
2) where vaccine baits were distributed, corresponding to the rabies endemic area
area of the territory, A the total area (km2) of the country under consideration
proportion of the territory ever
affected, P
the maximum proportion of the territory ever vaccinated (P ¼ V/A)
border length, B the length of the common boundary (km) between the area vaccinated in the focal country and the area
vaccinated in neighbouring countries
area index, I (IC100, IC90 and IC90p) an index capturing the mean spatial overlap and completeness of consecutive ORV campaigns in a country.
The mean index was calculated from the start of ORV until the last detected case, IC100; until initial
numbers of cases had been reduced by 90%, IC90 (but may have subsequently increased); and until this
reduction was maintained permanently, IC90p; see equation (2.1) and text
years of ORV experience, Y number of years since ORV ﬁrst began in Europe
rstb.royalsocietypublishing.org
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5more than one year, subsequent ORV campaigns were considered
new ORV programmes and the area index was re-calculated (table
1).
Three models were setup with the number of campaigns
required for control and elimination as dependent variables.
Mean area indices were calculated for the corresponding duration
of ORV programmes until control, permanent control, and elimin-
ation were achieved (IC90, IC90p and IC100). Correlations between
possible explanatory variables were examined using the Spearman
rank correlation coefficient [42] and only uncorrelated variables
were included in the analysis. The proportional hazards assump-
tion for a Cox regression model fit was tested as described
elsewhere [43,44].
Additional strategic variables relating to the design and
implementation of ORV, e.g. number of vaccine baits, bait den-
sity or the modes of bait distribution (hand/aerial) were not
considered in this analysis, because this information was not
available for all countries or changed over time.
For the majority of European countries included in this study,
direct and/or indirect expenditure on ORV programmes was not
available. However, cumulative vaccination area over time can be
used as a surrogate for financial expenditure on ORV following
methods previously described by Selhorst & Schlu¨ter [45]. In
their analysis, it was shown that total expenditure on ORV is pri-
marily owing to purchase of vaccine baits (market-based price)
followed by costs of bait distribution [26,45]. Both costs are deter-
mined largely by the area vaccinated during each campaign,
therefore the cumulative area vaccinated was considered a reason-
able approximation of ORV programme expenditure. Total direct
ORV programme costs (c, in euros) were approximated using the
number of baits distributed per square kilometre (b) and the cumu-
lative area vaccinated (a, in km2), as follows: c ¼ a(0.82 b þ 2.01)
[30]. We assume 20 baits km22 (b ¼ 20), which is the standard
bait density for oral vaccination of foxes in Europe, corresponding
to 18.41 euros per square kilometre vaccinated.
We used a linear mixed effects model to determine the
relationship between annual incidence in each county (Nt) and
approximate cumulative expenditure starting from the year of
ORV implementation until the year the last rabies case was
detected. Therefore the analysis was limited to countries that
eliminated rabies. The model was fitted using restricted maxi-
mum likelihood, with country as a random effect (see the
electronic supplementary material, figure S2) and the coefficient
l estimated as a fixed effect. The exponential decline in rabies
incidence with cumulative vaccination effort was modelledsince annual rabies incidence was loge transformed. Using this
relationship (equation (2.3)) we estimated the approximate finan-
cial expenditure c1/x required to reduce initial rabies incidence at
the start of ORV to N0/x.
Yðc1=xÞ ¼ Y0x ¼ Y0 expðlc1=xÞ
1
x
¼ expðlc1=xÞ
ln
1
x
 
¼ lc1=x
c1
x
¼ lnðxÞ=l ð2:3Þ
All analyses were performed using the ‘R’ programming
language [46].3. Results
During the past three decades, 24 European countries
implemented ORV programmes on their territories. Since
1978 the overall size of the area under vaccination in
Europe steadily increased to 614 773 km2 in 1996 as countries
in Western and Central Europe began to implement ORV pro-
grammes. From 1997 until 2006, the area under vaccination
remained relatively constant. Since 2000 ORV programmes
in several countries have been discontinued following suc-
cessful rabies elimination, while programmes have been
initiated in countries in Eastern Europe (table 1). The total
area under concurrent vaccination eventually peaked in
2007 at 1 077 370 km2 (figure 1). The total area ever covered
at least once with vaccine baits between 1978 and 2010
encompassed 1.92 million km2. The spatial extent and fre-
quency of ORV campaigns varied considerably, both within
countries and at a regional level, with the total number of
campaigns each country conducted between 1978 and 2010
ranging from one to 50 (figure 2a). In 12 countries ORV did
not encompass the entire territory (figure 2a).
As a result of the ongoing implementation of ORV, the
number of rabies cases reported annually in Europe steadily
declined from 17 202 in 1978 to 7581 in 2010 with intermediate
peaks in 1984 and 1989 (figure 1; electronic supplementary
material, figure S1). During this period nine countries
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6successfully eliminated fox rabies from their territory
(figure 2b,c and table 1; electronic supplementary material,
figure S1). The World Organization for Animal Health (OIE)
requires that no case be detected for a two-year period before
countries can be officially declared free from rabies [47]. Fin-
land and the Netherlands achieved rabies-free status in 1991
[48], Switzerland in 1998 [20], Belgium and Luxembourg in
2001 [48], the Czech Republic in 2004 [22] and Germany and
Austria in 2008 [26,49]. An imported dog rabies case with lim-
ited secondary transmission caused France to lose its rabies-free
status in 2008which it had achieved in 2000, but rabies freedom
was regained in 2010 [10]. Italy became rabies-free in 1997,
although fox rabies re-emerged on two subsequent occasions,
most recently in 2008 (table 1). Additionally, Slovakia reported
its last case in 2006 and could be regarded as rabies-free,
although it has not been officially declared rabies-free according
to OIE standards. Other countries now close to eliminating
rabies include Hungary where the last reported case was in
2010 and Lithuania, Estonia and Italy where only single cases
were reported in 2011 (www.who-rabies-bulletin.org).
The situation was very different amongst countries prior to
the implementation of their ORV programmes. For instance,
initial incidence ranged from 10 484 detected cases in Germany
to just 26 in Kaliningrad Oblast, Russia (table 1). Much of this
variation was attributable to the land area of countries with
endemic rabies, as evident in the significant positive correlation
between cases detected and territory size (Spearman’s rank cor-
relation, 0.43). However, there was still a large range in the
number of cases detected per square kilometre, varying from
0.05 cases km22 (Luxembourg) to less than 0.001 cases km22
(Bulgaria). Several significant correlations were detected
between other potential explanatory variables (see the elec-
tronic supplementary material, table S1). Correlated variables
were therefore excluded from further analysis, leaving the
area index, the proportion of the territory ever affected (P),the maximum area vaccinated (Vmax), and relative rabies inci-
dence (number of cases detected per square kilometre, Nkm2 )
as possible explanatory variables for the analysis of effort
required to control and eliminate rabies.
Control of rabies to less than 10 per cent of initial endemic
levels took a median number of 17 successive ORV cam-
paigns, but ranged from three to 62 depending on the
country. An additional four campaigns were required to
achieve permanent control, and an additional 11 campaigns
were required to eliminate rabies (median of 28 campaigns
to achieve elimination versus 21 for permanent control and
17 for control). Following stepwise model selection, the area
index and the proportion of a territory affected were found
to have significant effects upon the number of campaigns
required for control, permanent control and elimination
(table 3 and figure 3). For countries that implemented consist-
ently overlapping campaigns covering most of the affected
area and therefore with a mean area index close to one,
fewer campaigns were required in comparison with countries
that implemented relatively incomplete and non-overlapping
campaigns (for elimination: with P ¼ 0.95 and IC100 ¼ 1, a
median of 25 campaigns were required, versus 62 with
IC100 ¼ 0.2, figure 3a; for control: with IC90 equal to 1.0 and
0.2, 13 and 24 campaigns were required, respectively,
figure 3c). In contrast, the greater proportion of the territory
ever affected, the more ORV campaigns were necessary (for
elimination: 42 versus six campaigns for P ¼ 1.0 versus
0.02, with IC100 set to 0.65, figure 3b; for control: 23 versus six
campaigns, figure 3d). These results suggest that an increase
of one in the log-odds (logit) of the proportion of the territory
affected decreased the hazard of elimination by 55 per cent and
an increase of one in the log-odds of the area index more than
doubled the hazard of elimination (217%), whereas the impacts
on the hazard of control and permanent control were similar
but slightly smaller. As initial numbers of cases detected per
20101983
(a)
1
50
(c)(b)
Figure 2. ORV effort and rabies cases. (a) Spatial extent of ORV area and the total number of ORV campaigns conducted in each country between 1978 and 2010.
Reported rabies cases in (b) 1983 and (c ) 2010.
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7square kilometre increased, the number of campaigns requi-
red for permanent control also increased (table 3). For all
the models, the Cox-Snell Pseudo R2 values were relati-
vely low (R2¼ 0.28 for control, R2¼ 0.37 for permanent
control, R2¼ 0.48 for elimination, table 3).
The cumulative area vaccinated and therefore the
approximate expenditure by different countries to eliminate
rabies varied considerably. Poland and Germany were
amongst those that spent most on ORV, whereas rabies elim-
ination in Switzerland was relatively inexpensive (table 1).
For countries that eliminated rabies, a significant linear
relationship was found between cumulative area vaccinated
and loge rabies incidence (figure 4). Although the exponential
decline in incidence with increasing expenditure was evident
for all these countries, considerable variation was evident
from the random effects coefficients (see the electronic sup-
plementary material, figure S2). This pattern indicated that
increasing cumulative expenditure resulted in progressively
smaller reductions in rabies incidence until elimination
was achieved, albeit with high variation between countries
(see the electronic supplementary material, figure S2). Cumu-
lative effort to reduce initial incidence by 50 per cent followed
an almost linear increase, whereas disproportionally greater
effort was required in the final phase of elimination (figure 4).
The approximate expenditure required to reduce initialincidence (N0) to N0/x was estimated as: c1/x¼ loge(x)/
20.9257 (see equation (2.3), figure 4).4. Discussion
The elimination of fox rabies from Europe represents possibly
the most extensive and successful example of a vaccination
programme targeting wildlife to date. In recent decades sub-
stantial progress in rabies control has been made in many
parts of the world. Mass dog vaccination eliminated canine
rabies from Europe and much of the Americas [10,50],
almost exclusively relying upon parenteral delivery. The
development of ORV has made the elimination of disease
from wildlife reservoirs a reality. Over a period of three dec-
ades, vaccine baits have been distributed across nearly
1.9 million km2 of Europe, with nine previously endemic
countries now being rabies-free (figures 1, 2 and table 1;
electronic supplementary material, figure S1,). Previous evalu-
ations of ORV in Europe have focused on individual countries
[19,20,23,26–28], with only one descriptive study assessing ter-
ritorial differences and factors contributing to ORV success,
including vaccine strains, and bait density. The latter covered
the period from 1978 until 1994 when ORV was considered a
work in progress as no countries had yet achieved rabies
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8freedom [29]. Here,we provide the first comparative analysis of
the efficiency of ORV in Europe and factors influencing the
effort required to control andultimately eliminate rabies, focus-
ing on initial epidemiological conditions (table 1), geography
and vaccination strategy.
Of the 24 European countries that have implemented ORV
programmes, Finland and Turkey were excluded from our
analysis. Finland was rabies-free until 1988 when fox rabies
was introduced to the southeast of the country, most likely
by rabid wolves. The resulting outbreak, which predominately
affected raccoon dogs, was contained within a restricted area
and eliminated after three ORV campaigns [51]. Turkey is the
only country in Europe where dog-mediated rabies remains a
problem. Sustained rabies transmission in foxes occurred in
the Aegean region of Turkey following a spillover from dogs.
Three ORV campaigns were undertaken during the winter
months between 2008 and 2010. Although these demonstrated
the feasibility of wildlife rabies control by ORV in Turkey [52],
the impacts are difficult to assess for the entire country because
of persisting dog-mediated rabies [10].
Successive ORV campaigns led to relatively rapid reduc-
tions in rabies incidence (table 1 and figure 4), typically
bringing disease under control (more than 90% reduction in
detected cases) within 10 years, and in many cases less than
five years. However, the final stages of elimination typically
required an additional 10 or more campaigns before the last
case was detected, with ORV needing to be maintained for
a further 2 years without any detected cases for certification.
Previous research suggested that rabies could be eliminated
from a region within 10–12 campaigns, i.e. 5–6 years [41,53].
But countries that successfully eliminated rabies in Europe
required substantially longer (figure 3), with a median of 28
campaigns (14 years, range: 5–26) to achieve elimination,
and 17 for control. Favourable topographical features may
have contributed to the swift elimination of rabies from some
European regions after only a few ORV campaigns, such as
mountain ranges in Switzerland [31], while a number of
other factors may have prolonged progress to elimination.
The proportion of a territory ever affected by rabies and
the area index both had a decisive influence on ORV success
(see the electronic supplementary material, tables S1 and S3;
figure 3). The area index captures the comprehensiveness of
ORV in terms of the extent and spatial overlap of consecutive
ORV campaigns [41]. Among the 22 countries area indices
varied considerably from 0.006 to 1 (table 1). The closer
the mean area index was to one, the fewer campaigns
were needed to both control and eliminate rabies (figure 3).
A high mean area index reflects sufficiently sustained vacci-
nation coverage in the fox population to maintain herd
immunity and thereby interrupt rabies transmission, despite
high population turnover [13,41]. The finding that the pro-
portion of the territory affected correlates with campaigns
required to control and eliminate rabies may reflect more iso-
lated areas more quickly becoming free from disease, with
elimination more likely in smaller regions simply by chance
[41]. Otherwise, modelling suggests that time to control or
elimination should be independent of the size of the affected
area, assuming the same ORV strategy was applied [53].
Speculation that countries with high incidence, e.g. Swit-
zerland, Austria, Germany and Hungary (table 1) require
greater effort to eliminate disease [29] was not corroborated,
though countries with higher incidence per square kilometre
required more ORV effort to achieve maintained reductions
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Figure 3. Factors influencing the efficiency of ORV programmes in the control and elimination of rabies. To illustrate the influence of the area index (I ) and of the
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9in rabies incidence. This may be indicative of a more enduring
effect, as improvements in surveillance may have reduced the
power of our analyses of control, because we used initialendemic levels as a baseline. Surveillance considerably
improved in some countries across the continent over the last
few decades, even as the disease was progressively eliminated
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Figure 4. Estimated effort required to reduce rabies incidence. Accumulated financial expenditure (in euro) versus the proportional reduction in rabies cases from
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A mixed model with country as a random effect was used to estimate l (in equation (2.3). The fixed effect coefficient l (20.926) was used in the modelled
relationship of the exponential decline in rabies incidence with increasing cumulative expenditure on ORV according to equation (2.3).
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10(figure 2b,c). International recommendations have suggested
sample sizes for wildlife rabies surveillance [8,37,38]. While
useful for monitoring bait uptake, this approach is arbitrary
and inappropriate for case detection, because only suspect ani-
mals should be examined [54]. Our analyses instead suggest
that it is more important to ensure that the extent of surveil-
lance is sufficiently widespread for case detection across the
endemic area, to effectively define the area for ORV.
ORV campaigns are undoubtedly easier to organize and
manage across smaller spatial scales. In large countries ORV
is often hampered by management and structural deficiencies.
For instance, federal structures in Germany and Poland likely
caused difficulties in individual regions [25,26,55] prolonging
elimination at a national level (table 1). Although ORV pro-
grammes should ideally cover the entire affected area [41],
larger countries often started ORV in restricted areas owing
to logistical challenges and resource availability [26,32,48].
This is illustrated by the example of Romania, where despite
approval for reimbursement of ORV costs by the EU, no
budget was allocated for some years delaying implementation
(P. Demetriou 2012, personal communication). The Baltic
countries did not vaccinate the entire affected area from the
beginning [23], and initial ORV attempts in Latvia and Lithua-
nia failed to efficiently control rabies and were interrupted
owing to budget constraints (table 1). Hence, subsequent ORV
didnot benefit fromprevious efforts and resourceswerewasted.
The type of vaccine usedhas been reported to be key toORV
success [23,48], however regional assessments have failed to
reveal any association [29]. We, therefore, assume negligible
differences between vaccines used in this study since all met
the international regulations for quality control. Unfortunately,
strategic factors other than the area index, e.g. optimal timing ofcampaigns, proportion of aerial versus hand distribution, exact
bait density and variation in flight line distances, could not be
analysed because of incomplete data [56–58].
We did not find any effect of shared borders between
countries on the number of campaigns required for control or
elimination. Yet, numerous examples of incursions (France–
Switzerland (1990), France–Belgium–Germany (1993), Italy–
Slovenia–Austria (1993), Germany–Poland–Czech Republic
(1995) and Italy–Slovenia (2008) [26,28,29,59]) demonstrate
the risk posed from neighbouring endemic areas and the need
for coordinated cross-border activities [21,23,26]. In 2012, fox-
mediated rabies spread from the Former Yugoslavian Republic
of Macedonia (FYROM) into Greece, a country which was
previously rabies-free (www.who-rabies-bulletin.org), whereas
insufficient cross-border cooperation between federal states
was the main obstacle to elimination in Germany [26]. Our
analysis only crudely captures shared border length for the
entire observation period while the risk varies over time
depending on the rabies situation in adjacent areas. A more
comprehensive approach that accounts for the inherent spatio-
temporal transmission dynamics at border regions is therefore
merited in future.
Costs of ORV vary greatly across North America and
Europe [23,26,60–62] and detailed cumulative costs (direct
and indirect) can only be calculated on a country basis. Never-
theless, direct ORV costs are largely driven by the area
vaccinated, allowing a rough approximation of investment
required for proportional declines in incidence [45]. Despite
substantial differences between countries, the greater pro-
portion of a territory infected, the higher are the costs of
control (table 1 and figures 3, 4). Besides the proportion of
the territory affected, there are several other reasons why for
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11example Poland and Germany are amongst those that spent
most on ORV (table 1). In Germany, in the late 1990s, residual
foci of infection persisted in the federal states of North-Rhine
Westphalia, Saxony andHesse, the latter leading to re-infection
of adjacent areas in Baden-Wu¨rttemberg and Rhineland-
Palatinate, greatly prolonging rabies elimination [26]. Despite
considerable progress in Poland, legal issues prevent the cessa-
tion ofORV in rabies-free regions, at great expense. Anupsurge
of rabies in the Malopolskie region in 2010 in Poland caused a
similar setback to that faced byGermany.While the reasons for
this remain speculative [55] it is likely that this area was some-
what neglected in ORV efforts. Further analyses are needed
to elucidate country-based differences in the cost effectiveness
of ORV.
Our analysis demonstrated a roughly exponential decline
in rabies cases with cumulative ORV expenditure. Therefore
although ORV efforts reduce incidence, more effort is
needed for the same payoff during the endgame (figure 4).
This result is in line with the findings from the Cox-
proportional hazard model that once rabies has been brought
under control, which on average requires 17 ORV campaigns,
an additional 11 ORV campaigns are needed to progress from
a 90 per cent reduction in incidence to elimination. A similar
trend has been observed for other elimination programmes,
e.g. polio and smallpox [63–65]. Modelling results corrobo-
rate this phenomenon of long-lasting low-level persistence
of rabies within vaccinated populations, both in wildlife
and in dogs [53,66]. Despite vaccination suppressing inci-
dence, clusters of infection are able to persist and spread,
even in areas with a high area index; high levels of coverage
are needed for more rapid elimination [53], whereas even
small pockets of low coverage can compromise success and
considerably extend the time to elimination [66]. Rapid
reductions in incidence led to overly optimistic projections
of ORV success by veterinary authorities, and premature
budget cuts and/or declaration of areas as being ‘rabies-
free’, frequently followed by subsequent re-emergence [58].
It is, therefore, of utmost importance to consolidate available
resources to ensure comprehensive coverage eliminates any
residual foci and prevents escalating costs.
Most EU member states and a few countries bordering the
EU have eliminated rabies, or are on target for elimination in
the near future, while countries in Eastern Europe are in the
early stages of control. The establishment of a ‘cordon sani-
taire’ is required to prevent the return of rabies to these
areas, which means that border countries will always
remain in the ‘endgame’ [67]. The EU is promoting the estab-
lishment of a vaccination belt in rabies endemic non-EU
countries by co-financing [18]. Although largely effective,
these immune barriers are not entirely impermeable, as the
2008 incursion into Northern Italy from the Balkan peninsula
beyond the vaccination zone in Slovenia showed [68]. But the
emergence of fox rabies in Greece in 2012 could have been
anticipated, given that no preventive vaccination belt hadbeen established when cases were detected in neighbouring
border areas in the FYROM. All European countries also
need to maintain a high level of vigilance, as rabies could
be introduced via illegally imported animals [69], and aware-
ness often falls following a prolonged absence of disease and
cessation of ORV will lead to a build up of susceptibles.5. Conclusions
The sustained effort and enormous geographical extent of
ORV (figures 1 and 2) that has led to the successful control
and elimination of fox rabies from vast areas of Europe is
unprecedented for a wildlife disease [10]. We show that the
extent to which a territory is affected influences the time to
elimination, with ORV campaigns implemented in a compre-
hensive sustained manner (high I ) more rapidly bringing
disease under control. The final phase of elimination is dis-
proportionally the most costly (figure 4), with increasing
ORV effort resulting in diminishing reductions in rabies
cases. Once brought under control, almost as many ORV
campaigns are needed again to eliminate infection and main-
tain vaccination for long enough to certify freedom from
disease. Therefore, a concerted ORV strategy including
common coordination of cross-border activities is essential
to save costs, with enough resources retained for the elimin-
ation stage. Our results indicate that the most efficient ORV
programmes should vaccinate fully across the extent of the
affected area and should secure adequate funding for a suffi-
cient period of time to enable sustained vaccination with a
high area index [28]. Despite the initially high investment
needed for this strategy, fewer campaigns will be required
to eliminate rabies, resulting in cost savings (figure 3). In
any case, funding should include campaigns for two
additional years after the last rabies case [51]. While rapid
early successes in disease control are encouraging, policy
makers must be prepared for continued commitment for
elimination, and not be tempted to prematurely discontinue
elimination programmes, because the final mile requires the
greatest investment.
Elimination of fox rabies in Europe would not have been possible
without the motivation, continuous effort, support and assistance
of the responsible veterinary and public health authorities, hunters
as well as all other involved stakeholders. The submission of rabies
and ORV related data to the WHO Rabies Bulletin Europe by respon-
sible staff of ministries and national reference laboratories for rabies
throughout Europe is gratefully acknowledged. This study was
undertaken in the frame of a lyssavirus research network financially
supported by the German Ministry for Education and Research
(BMBF, grant no. 01KI1016A) and K.H. was supported by the
Wellcome Trust, the Medical Research Council, UK and the Research
and Policy for Infectious Disease Dynamics (RAPIDD) programme
of the Science and Technology Directorate, US Department of
Homeland Security, and the Fogarty International Center, National
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